Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome

Mirati Therapeutics shares are trading higher after in sympathy with Amgen after the company presented Phase 1 data on its KRAS G12C inhibitor, AMG 510; Mirati is also developing a KRAS G12C inhibitor.


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: WIIM Markets


Related Articles (MRTX)

Lightning Fast
Market News Service
$199 Free 14 Day Trial

Today's Pickup: New Lithium Mining Process Drastically Cuts EV Production Costs

A New ETF To Refresh The Value Factor